Olympics Foreshadow Beijing's Intention To Follow Own Policy Path?
Related Lower Need For Pandemic Vaccines, Drugs?
The Beijing Winter Olympics highlight a changing China that is becoming more confident and confrontational in its policies, although a willingness to challenge international rules could potentially stall the further introductions of novel vaccines and treatments at a critical juncture of the pandemic.
You may also be interested in...
Amid China’s increasingly inward-looking and dual circulation economic policies, the Beijing Winter Olympics provide rare insight into policymakers’ handling of a global event.
While many pharma firms in China choose to partner with US companies, Jiangsu Hengrui is relying on itself to go global. The Chinese pharma giant is betting on its newly established US subsidiary Luzsana in a major move to make its wide-ranging products more available, accessible and affordable to patients in the US and the rest of the world.
Home-grown Chinese mRNA COVID-19 vaccines are more effective than domestic inactivated virus-based shots, new trial results show.